Reveals the study that the genetic profile of placentas varies according to the sex of the baby

1. Cover
2. Articles
3. Science and the Environment
4. Medicine

Monday, July 16, 2018 – 13:24:58 | 67 | |
Categories

In this article: Camagüey, Cuba, health, medicine, pregnancy, risks

London, July 16.- The risks of certain diseases during pregnancy vary by bad of the baby who controls the level of small molecules known as metabolites in the mother's blood, today published specialized media.

From the University of Cambridge in the UK, the study helps to understand why male babies in the uterus are more vulnerable to the effects of poor growth and how the pregnancy of females gives a higher risk of pre-eclampsia for the mother.

For research, more than four thousand new mothers were examined, to whom detailed scientific studies were conducted such as the badysis of the placenta and maternal blood.

Scientists found that the genetic profile of placentas of both bades was very different by bad of the same and that one of the unique bad-related placental genes controls the level of the spermine molecule.

This small molecule is a metabolite – a substance involved in metabolism – that plays an important role in cells and is even essential for the growth of certain bacteria.

Female placentas had much higher levels of the enzyme that produced spermine and mothers recorded higher levels of a form of this molecule in the blood compared to pregnant mothers with [19659009] It was also determined that children's placental cells were more sensitive to the toxic effects of a drug that blocked their production, which provided direct experimental evidence on bad-related differences in metabolism. placental spermine.

Gordon Smith, head of research, said that "in the Mbarazo and childbirth, the baby's gender is in the vanguard of many parents' minds, but we do not even think that the placenta has bad.This work shows that the placenta differs profoundly by bad. "

The differences found to alter the elements of blood composition of the mother and may even change the risk of complications of pregnancy, she said.

Smith pointed out that "a better understanding of these differences could lead to new predictive tests and perhaps even new approaches to reduce the risk of a poor pregnancy outcome." (PL) (Photo: Archivo)